Pulmonology Medical News about Pertussis Vaccine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bordetella pertussis and Pertussis Vaccines
Clinical Infectious Diseases, 10/28/09

Guiso N – The use of pertussis whole–cell vaccines in infants and toddlers led to decreased circulation of the bacterium in the child population and a marked decrease in the incidence of the disease. However, vaccine does not result in life–long immunity; indeed, the circulation of the bacterium has not been controlled in the adult population. Universal adult booster immunization is now possible using pertussis acellular vaccines, which target–and are thus likely to control–the virulence of this bacterium.

<< Previous
First documentation of isoniazid reversion in Mycobacterium...

Next >>
Risk Factors and Clinical Impact of Klebsiella pneumoniae...

CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09 Relevance Score: 70%

Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: Systematic review of randomized controlled trials and quasi-randomized controlled trials
Clinical Therapeutics, 10/16/09 Relevance Score: 68%

Keeping Vulnerable Children Safe from Pertussis: Preventing Nosocomial Pertussis Transmission in the Neonatal Intensive Care Unit
Infection Control and Hospital Epidemiology, 10/13/09 Relevance Score: 68%

Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults
Expert Review of Vaccines, 10/07/09 Relevance Score: 64%

A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09 Relevance Score: 49%